Self-adjuvanted RNActive® vaccine induces local immune responses at the injection site leading to potent adaptive immunity in mice and humans

Meeting abstracts Two-component mRNA-based vaccine (RNActive®) combines high antigen expression with strong immune stimulation. We have previously shown that intradermal administration of RNActive® vaccines induced balanced, potent and long-lasting immune responses in both mice and humans. Here,